Exclusive-Eisai expects 1,500 Alzheimer’s patients in China launch, sees ‘huge’ growth February 4, 2024
Japan’s Eisai aims to roll out its groundbreaking Alzheimer’s drug Leqembi to 1,500 people in China later this year, but expects growth to accelerate significantly in 2025 as diagnosis methods change, ...